Sterile Fill Finish
Curia is your partner for integrated sterile drug product manufacturing needs.
Leverage our expertise and capabilities for your sterile drug product manufacturing needs at any scale, from early clinical through large-scale commercial supply.
We provide a complete suite of services for all sterile dosage forms—routinely handling nearly every category of sterile liquid, suspended or lyophilized biological or pharmaceutical product, aseptically filled and/or terminally sterilized on a commercial-sized scale.
For seamless project transition, leverage our integrated sterile dosage form development and manufacturing expertise within a single organization.
Albuquerque, NM, US
| Bulk Capacity | GMP Dose Filling Lines | Validated For | Non-cyto? | Cyto/Highly Potent? |
|---|---|---|---|---|
| 200–1800 L | Vials and syringes | 2–100 mL vials | Liquid and lyophilized | Liquid and lyophilized |
Expertise and Capabilities
- Suspensions
- Liposomes and nanoparticles
- Proteins/Peptides
- Monoclonal antibodies
- Inactivated and attenuated live vaccines
- DEA registered products
- Clinical and commercial
Burlington, MA, US
| Bulk Capacity | GMP Dose Filling Lines | Validated For | Non-cyto? | Cyto/Highly Potent? |
|---|---|---|---|---|
| 40–200 L | Vials and syringes | 2–30 mL vials 1 mL Long, 1–3 mL, and 10 mL syringes |
Liquid and lyophilized | Liquid |
Expertise and Capabilities
- Biologics and small molecules
- Viscous biopolymers
- Suspensions
- Liposomes and nanoparticles
- Microfluidization and high-shear homogenization
- Extrusion
- Controlled drugs (Schedule II-V)
- Clinical and commercial
Camarillo, CA / Thousand Oaks, CA, US
| Bulk Capacity | GMP Dose Filling Lines | Validated For | Non-cyto? | Cyto/Highly Potent? |
|---|---|---|---|---|
| 100 L | Vials, syringes, cartridges, and manual | 2–30 mL vials, 1-2.25 mL Pre Filled Syringes | Liquid, lyophilized, solution, suspension | No |
Expertise and Capabilities
- Large molecule formulation development including RNA, Viral Vectors, mAbs, proteins, peptide, oligonucleotides
- High concentration formulation technology
- Lyophilization process development and optimization
- RABS (Restricted Access Barrier System)
- Proteins/peptides
- Monoclonal antibodies
- Clinical supply
- Full in-house analytics
- Novel container closure systems
Glasgow, UK
| Bulk Capacity | GMP Dose Filling Lines | Validated For | Non-cyto? | Cyto/Highly Potent? |
|---|---|---|---|---|
| <50 L | Vials and manual | 2–50 mL vials | Liquid and lyophilized | Liquid and lyophilized |
Expertise and Capabilities
- Lyophilization process development and optimization
- Antibody drug conjugates
- Proteins/peptides
- Monoclonal antibodies
- Controlled drugs (Schedule I to V)
- Clinical supply
